Viewpoint
European Journal of Human Genetics (2007) 15, 260–263. doi:10.1038/sj.ejhg.5201753; published online 13 December 2006
Are genome-wide association studies all that we need to dissect the genetic component of complex human diseases?
Catherine Bourgain1, Emmanuelle Génin1, Nancy Cox2,3 and Françoise Clerget-Darpoux1
- 1INSERM U535, University Paris Sud, Villejuif F-94817, France
- 2Department of Medicine, University of Chicago, Chicago, IL, USA
- 3Department of Human Genetics, University of Chicago, Chicago, IL, USA
Correspondence: Dr C Bourgain, INSERM U535, University Paris XI, Genetique Epidemiologique et Structure des Populations Humaines, Hopital Paul Brousse, Batiment Leriche, B.P. 1000, Villejuif, Cedex 94817, France. Tel: +33 1 45 59 53 85; Fax: + 33 1 45 59 53 31; E-mail: bourgain@vjf.inserm.fr
Received 1 June 2006; Revised 12 September 2006; Accepted 27 October 2006; Published online 13 December 2006.
Abstract
With the availability of dense maps of anonymous and frequent SNPs spanning the whole human genome, genome-wide association studies are now becoming a reality. In this paper, we discuss the utility of these approaches to detect genetic risk variants involved in complex disease susceptibility and, in the best case scenario where a signal is detected, how helpful it will be to the understanding of the pathological process.
Keywords:
genome-wide association study, power, modelling
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

